The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - OncImmune
Patents, Royalties, Other Intellectual Property - Oncimmune holds patents and intellectual property in technologies and biomarkers related to the abstracts. I am inventor of the research data leading to the patents. I do not receive royalties. (Inst)
Autoantibodies as predictors for survival and immune-related adverse events in checkpoint inhibition therapy of metastasized melanoma.
 
Jessica Cecile Hassel
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD; Pierre Fabre; Sun Pharma
Research Funding - 4SC (Inst); Amgen (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Idera (Inst); Immunocore (Inst); Novartis (Inst); Philogen (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pierre Fabre
 
Hans-Dieter Zucht
Employment - Oncimmune; Protagen
Patents, Royalties, Other Intellectual Property - Biomarker patents autoimmune targets - multiple
 
Joanna Mangana
Honoraria - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Merck/Pfizer; Novartis; Pierre Fabre
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme; Merck/Pfizer; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; L'Oreal; Merck Sharp & Dohme; Pierre Fabre; Pierre Fabre; Ultrasun
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Claudia Pföhler
Honoraria - Abbvie; Bristol-Myers Squibb; Celgene; LEO Pharma; Merck Serono; MSD; Novartis; Roche
Consulting or Advisory Role - Merck Serono; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Celgene; LEO Pharma; Merck Serono; MSD; Novartis; Roche
 
Kilian Wistuba-Hamprecht
Research Funding - Catalym (Inst)
 
Benjamin Weide
Consulting or Advisory Role - Philogen
Research Funding - Bristol-Myers Squibb (Inst); Philogen (Inst)
 
Lara Elena Hakim-Meibodi
No Relationships to Disclose
 
Friedegund Elke Meier
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Sanofi
 
Carsten Schulz
No Relationships to Disclose
 
Manuel Bräutigam
Employment - OncImmune
 
Petra Budde
No Relationships to Disclose